340B Cuts Could Hurt Small, Rural and DSH Healthcare Providers
June 6, 2018 The $1.6 billion reduction in the federal 340B Drug Discount Program that went into effect in 2018 could negatively impact the operating performance of many participating non-profit hospitals, credit research firm S&P Global Ratings has reported. The Centers for Medicare & Medicaid Services (CMS) has reduced 340B payments by about 30 percent for most medication for 2018. According to a 2015 report by the Medicare Payment Advisory Commission, about half of United States hospitals are now 340B participants. The…